SUBSCRIBE
SUBSCRIBE

Biovest International, Inc. Announces Upcoming Conference Calendar to Present on Personalized Cancer Vaccine Targeting B-cell Lymphomas

March 17, 2010 | 
1 min read

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (Other OTC:BVTI) today announced that the company is confirmed to present its personalized cancer vaccine, BiovaxID®, at the following upcoming conferences:

Events
MORE ON THIS TOPIC
Editorial
Transparency Missing in Action at HHS Despite Leaders’ Calls for Clarity
February 28, 2025
 · 
4 min read
 · 
Heather McKenzie
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Cancer
BMS, Pfizer Challenge Colorectal Cancer Standard Care With ASCO GI Readouts
January 27, 2025
 · 
2 min read
 · 
Tristan Manalac
San Francisco, USA - May 20, 2022: historic Cable Car Powell Hyde Line on turntable at Powell Street terminal at Market Street in downtown San Francisco, California CA, USA.
Pipeline
JPM25 Day 3: AbbVie, Gilead, GSK and Dyne
January 16, 2025
 · 
3 min read
 · 
Tristan Manalac
Pictured: Aerial view of the San Francisco skyline
Pipeline
JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen
January 15, 2025
 · 
4 min read
 · 
Tristan Manalac